| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
15,615 |
14,318 |
$1.10M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,862 |
3,861 |
$356K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,978 |
2,911 |
$290K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
6,467 |
6,180 |
$247K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,502 |
2,440 |
$73K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
328 |
297 |
$47K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,576 |
2,491 |
$42K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
276 |
276 |
$36K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,061 |
2,026 |
$30K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
52 |
52 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
103 |
95 |
$4K |
| 99051 |
|
431 |
421 |
$3K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
34 |
34 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,330 |
1,304 |
$2K |
| 86328 |
|
30 |
29 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
448 |
439 |
$888.45 |
| 87807 |
|
68 |
67 |
$792.20 |
| 71045 |
Radiologic examination, chest; single view |
14 |
14 |
$284.14 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
144 |
141 |
$257.38 |